In line with these findings, our study shows that patients with a cardiometabolic inflammatory profile (obesity, diabetes, hypertension, arthritis) show better SEC survival, thus giving IL17 a central role in the pathogenesis of this inflammatory phenotype. The gene discussed is IL17A; the disease is obesity due to melanocortin 4 receptor deficiency.